https://www.integratedpharmaservices.com/items-5/development-of-an-artificial-human-skin-testing-model-for-evaluation-of-candidate-wound-care-products- 2023-02-27 https://www.integratedpharmaservices.com/items-5/antimicrobial-efficacy-evaluation-of-a-next-generation-handheld--cold-plasma-technology-against-drug-resistant-pathogens 2023-02-27 https://www.integratedpharmaservices.com/items-5/a-novel-platform-for-culturing-and-testing-of-polymicrobial-communities 2023-02-27 https://www.integratedpharmaservices.com/items-5/development-of-an-artificial-human-skin-testing-model-for-evaluation-of-candidate-wound-care-products- 2023-02-27 https://www.integratedpharmaservices.com/items-5/antimicrobial-efficacy-evaluation-of-a-chlorite-based-immunomodulating-drug 2023-02-27 https://www.integratedpharmaservices.com/items-5/antimicrobial-efficacy-evaluation-of-a-portable-cold-plasma-technology-on-artificial-human-skin 2023-02-27 https://www.integratedpharmaservices.com/items-5/an-immunomodulating-drug-for-treating-wound-infections- 2023-02-27 https://www.integratedpharmaservices.com/items-5/application-of-a-next-generation-hand-held-antimicrobial-cold-plasma-technology 2023-02-27